Doctors Note Logo

Published on: 9/15/2026

How long does bupropion anxiety last before it finally settles down?

Anxiety, jitteriness, and restlessness are common when starting bupropion or increasing the dose, and for most people these effects peak within the first one to two weeks and ease within two to four weeks as the body adjusts. Some people notice lingering agitation for six weeks or longer, especially at higher doses or with immediate-release forms, and that pattern can signal a need for a dose change, a switch to XL, or a different medication. Timing, caffeine intake, sleep, and whether the anxiety is worsening rather than fading all matter, so there are several important factors to consider before deciding to wait it out. See below for the full timeline, warning signs that require prompt medical attention, and practical ways to reduce early side effects.

If you are unsure whether your symptoms reflect normal adjustment or something that needs attention sooner, a free, instant, online symptom check can help you organize what you are feeling, see possible explanations, and understand which next step makes sense, all in a few minutes and without leaving home.

Last reviewed for medical accuracy: 09/15/2026

answer background

Explanation

How Long Does Bupropion-Related Anxiety Last Before It Settles Down?

Starting bupropion can be a relief for many people dealing with depression or quitting smoking. Yet for some, new or worsened anxiety can crop up in the first days or weeks. Understanding what to expect—and when it typically eases—can help you stick with treatment and feel more confident in managing side effects.

What Is Bupropion?

Bupropion is a prescription medication most often used to:

  • Treat major depressive disorder and seasonal affective disorder
  • Help people quit smoking (under brand names like Zyban)

Unlike many antidepressants that focus on serotonin, bupropion works on dopamine and norepinephrine pathways. This different approach often means fewer sexual side effects or weight gain, but it can sometimes increase feelings of nervousness or anxiety—especially at the start.

Why Anxiety Can Occur with Bupropion

Anxiety on bupropion may stem from:

  • Stimulant-like effects: Bupropion’s action on norepinephrine can feel energizing, which for some resembles jitteriness.
  • Dose changes: Starting at a higher dose or increasing too quickly raises the chance of new anxiety.
  • Individual sensitivity: Everyone’s brain chemistry is unique—some people simply react more strongly.

Clinical trials and post-marketing reports suggest up to 10–20% of new bupropion users notice increased anxiety or restlessness early on.

Typical Timeline for Bupropion-Induced Anxiety

While individual experiences vary, most people see anxiety peak and then fade as their body adjusts:

  • Days 1–7
    • Onset: You may feel more jittery, restless or notice racing thoughts.
    • Intensity: Often mild to moderate. If you’re very sensitive, it could feel intense.
  • Weeks 2–4
    • Adjustment phase: Nervous energy usually begins to taper off as neurotransmitter levels stabilize.
    • Possible improvements in mood, sleep, and concentration start to appear.
  • Weeks 4–6
    • Settling phase: New anxiety is often significantly reduced or gone by the end of week six.
    • Fatigue or headaches (other common side effects) may also subside.
  • After Week 6
    • Maintenance: Most people no longer experience anxiety triggered by bupropion.
    • If anxiety persists, dose adjustments or a different medication may be needed.

Note: A small number of people might experience ongoing anxiety. If it continues beyond six weeks or gets worse at any point, talk to your doctor.

Factors That Influence How Long Anxiety Lasts

  • Starting dose and titration speed:
    Slower increases (for example, starting at 150 mg once daily, then moving to 150 mg twice daily after a week) often lessen early anxiety.
  • Other medications:
    Combining bupropion with stimulants or certain antidepressants can heighten anxious feelings.
  • Pre-existing anxiety disorders:
    If you’re already prone to panic attacks or chronic anxiety, you may notice side effects more intensely.
  • Lifestyle factors:
    Stress, caffeine intake, sleep quality and exercise can all affect anxiety levels.

Tips to Manage Bupropion-Related Anxiety

  1. Follow your prescriber’s dosing schedule
    • Don’t increase your dose too quickly.
    • If anxiety is too intense, ask about a slower titration or a temporary dose reduction.
  2. Practice relaxation techniques
    • Deep breathing exercises, progressive muscle relaxation or guided meditation can help calm racing thoughts.
  3. Limit stimulants
    • Cut back on coffee, energy drinks and nicotine while your body adapts.
  4. Maintain regular sleep habits
    • Aim for consistent bedtimes and wake times to support neurotransmitter balance.
  5. Stay active
    • Moderate exercise—like walking or yoga—can reduce anxiety and boost mood.

When to Seek Medical Advice

While most bupropion-related anxiety settles within 4–6 weeks, you should reach out to a healthcare professional if you experience:

  • Persistent or worsening anxiety beyond six weeks
  • Intense panic attacks or feelings of being out of control
  • New thoughts of self-harm or suicide
  • Any life-threatening or serious symptoms

If you’re unsure whether what you’re feeling is typical or serious, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.

Talking to Your Doctor

A frank conversation with your prescriber can help:

  • Adjust your bupropion dose or schedule
  • Add short-term anti-anxiety medication if needed
  • Explore alternative antidepressants

Always discuss any severe or alarming symptoms with a qualified professional. If you ever feel unsafe with your thoughts or behaviors, seek immediate medical attention.

Key Takeaways

  • Anxiety from bupropion usually peaks in the first week or two and subsides by week six.
  • Slow titration, lifestyle adjustments and relaxation techniques can ease early nervousness.
  • Persistent or severe anxiety warrants prompt medical review.
  • For peace of mind about your symptoms, try a free, online symptom check, using the doctor approved Ubie Symptom Checker.

Always remember: never stop or change your medication without talking to your doctor. If you experience any life-threatening or serious symptoms, seek emergency care right away.

(References)

  • * Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, Caldeira Brás I, Dawson J, Kay C, Caron NS, Hayden MR. Huntington Disease. 1993. PMID: 20301482.

  • * Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, Sharma V, Goldstein BI, Rej S, Beaulieu S, Alda M, MacQueen G, Milev RV, Ravindran A, O'Donovan C, McIntosh D, Lam RW, Vazquez G, Kapczinski F, McIntyre RS, Kozicky J, Kanba S, Lafer B, Suppes T, Calabrese JR, Vieta E, Malhi G, Post RM, Berk M. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018 Mar;20(2):97-170. doi: 10.1111/bdi.12609. Epub 2018 Mar 14. PMID: 29536616; PMCID: PMC5947163.

  • * Schwasinger-Schmidt TE, Macaluso M. Other Antidepressants. Handb Exp Pharmacol. 2019;250:325-355. doi: 10.1007/164_2018_167. PMID: 30194544.

  • * Sheffler ZM, Patel P, Abdijadid S. Antidepressants. 2026 Jan. PMID: 30844209.

  • * Naguy A, Badr BHM. Bupropion-myth-busting! CNS Spectr. 2022 Oct;27(5):545-546. doi: 10.1017/S1092852921000365. Epub 2021 Apr 12. PMID: 33843549.

  • * Alberter AA, Chambers AJ, Schaffer DH. Bupropion Toxicity. 2026 Jan. PMID: 35593803.

  • * DeBattista C, Schatzberg AF. The Black Book of Psychotropic Dosing and Monitoring. Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. doi: 10.64719/pb.4493. PMID: 38993656; PMCID: PMC11235576.

  • * Olagunju AE, Ghoddusi F. Attention-Deficit/Hyperactivity Disorder in Adults. Am Fam Physician. 2024 Aug;110(2):157-166. PMID: 39172673.

  • * Manter MA, Birtwell KB, Bath J, Friedman NDB, Keary CJ, Neumeyer AM, Palumbo ML, Thom RP, Stonestreet E, Brooks H, Dakin K, Hooker JM, McDougle CJ. Pharmacological treatment in autism: a proposal for guidelines on common co-occurring psychiatric symptoms. BMC Med. 2025 Jan 7;23(1):11. doi: 10.1186/s12916-024-03814-0. Epub 2025 Jan 7. PMID: 39773705; PMCID: PMC11705908.

  • * Oldak SE, Maristany AJ. Bupropion and Anxiety: A Brief Review. Hum Psychopharmacol. 2025 Sep;40(5):e70018. doi: 10.1002/hup.70018. PMID: 40958494.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.